Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediterra is a Greek biopharmaceutical and consumer health company primarily focused on the development and commercialization of products derived from Chios Mastiha (mastic gum). The company operates through its retail brand Mastihashop and a dedicated research arm that explores the therapeutic properties of mastic gum in gastrointestinal, oral, and metabolic health. Mediterra has collaborated with academic institutions to conduct clinical trials, most notably investigating mastic gum's efficacy in treating Crohn's disease and eradicating Helicobacter pylori. Their business model integrates traditional agricultural production with modern pharmaceutical research to provide natural-based therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediterra.